Investing Profile

Michael Powell

InvestorVC
Executive Partner at Omega Funds
Photo of Michael Powell, Partner at Omega Funds
cb
Omega Funds Partner
$100K - $5.0M
$1.5M
16
CompanyStageDateRound SizeTotal Raised
Aerium Therapeutics
Series AMar 2022
Co-investors: Stephen Knight (F-Prime Capital Partners), Vincent Ossipow (Omega Funds)
Checkmate Pharmaceuticals
Series CJun 2020$85M
Series BJun 2017$27M
Series AAug 2015$20M
$150M
Co-investors: Ben Auspitz (F-Prime Capital Partners), Corey Goodman (venBio), Daniel Coley (Cofounders Capital)
Veridium
Series BJun 2018$17M
$17M
Pionyr Immunotherapeutics
Series BDec 2017$62M
$79M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Arjun Goyal (Vida Ventures), Jack Kenney (SV Health Investors), Leon Chen (The Column Group)
Mirna Therapeutics
Series DApr 2015$42M
Series COct 2012$35M
$77M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Bill Harrington (Osage University Partners)
Labrys Biologics
Series AJan 2013$31M
Series UnknownDec 2012$15M
$46M
Co-investors: Wende Hutton (Canaan Partners), Nina Kjellson (Canaan Partners)
Intellikine
Series BJul 2009$51M
Series BJun 2007$30M
$81M
DiObex
Series BApr 2007$24M
Series ASep 2005$7M
$31M